SHSE:688016 (China)
Â
Class A
Â¥
119.10
(+2.43%)
Dec 24
Business Description
Shanghai Microport Endovascular Medtech Co Ltd
ISIN : CNE100003MJ5
Share Class Description:
SHSE:688016: Class ACompare
Compare
Traded in other countries / regions
688016.China IPO Date
2019-07-22Description
Shanghai Microport Endovascular Medtech Co Ltd is primarily engaged in the development, production and sales of medical devices for aortic and peripheral vascular interventions.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 95 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | 435.64 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 15.36 | |||||
| Beneish M-Score | -1.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 36 | |||||
| 3-Year EBITDA Growth Rate | 32.1 | |||||
| 3-Year EPS without NRI Growth Rate | 34.2 | |||||
| 3-Year FCF Growth Rate | 24.2 | |||||
| 3-Year Book Growth Rate | 39.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 19.98 | |||||
| Future 3-5Y Total Revenue Growth Rate | 22.45 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.38 | |||||
| 9-Day RSI | 58.76 | |||||
| 14-Day RSI | 58.53 | |||||
| 6-1 Month Momentum % | -2.62 | |||||
| 12-1 Month Momentum % | -15.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.01 | |||||
| Quick Ratio | 5.49 | |||||
| Cash Ratio | 4.87 | |||||
| Days Inventory | 258.12 | |||||
| Days Sales Outstanding | 61.59 | |||||
| Days Payable | 56.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.01 | |||||
| Dividend Payout Ratio | 0.55 | |||||
| 3-Year Dividend Growth Rate | 52.4 | |||||
| Forward Dividend Yield % | 4.01 | |||||
| 5-Year Yield-on-Cost % | 4.09 | |||||
| 3-Year Average Share Buyback Ratio | -4.7 | |||||
| Shareholder Yield % | 4.07 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 75.43 | |||||
| Operating Margin % | 52.83 | |||||
| Net Margin % | 51.83 | |||||
| FCF Margin % | 30.73 | |||||
| ROE % | 18.51 | |||||
| ROA % | 16.33 | |||||
| ROIC % | 49.91 | |||||
| ROC (Joel Greenblatt) % | 167.63 | |||||
| ROCE % | 20.69 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.89 | |||||
| Forward PE Ratio | 20.41 | |||||
| PE Ratio without NRI | 21.67 | |||||
| Price-to-Owner-Earnings | 27.66 | |||||
| PEG Ratio | 0.67 | |||||
| PS Ratio | 11.23 | |||||
| PB Ratio | 3.78 | |||||
| Price-to-Tangible-Book | 5.14 | |||||
| Price-to-Free-Cash-Flow | 36.05 | |||||
| Price-to-Operating-Cash-Flow | 23.1 | |||||
| EV-to-EBIT | 15.64 | |||||
| EV-to-EBITDA | 15.64 | |||||
| EV-to-Revenue | 9.35 | |||||
| EV-to-FCF | 30.47 | |||||
| Price-to-Projected-FCF | 2.43 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.87 | |||||
| Price-to-Graham-Number | 2.23 | |||||
| Price-to-Net-Current-Asset-Value | 6.07 | |||||
| Price-to-Net-Cash | 8.03 | |||||
| Earnings Yield (Greenblatt) % | 6.39 | |||||
| FCF Yield % | 2.67 | |||||
| Forward Rate of Return (Yacktman) % | 21.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Microport Endovascular Medtech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,268.309 | ||
| EPS (TTM) (Â¥) | 5.44 | ||
| Beta | 1.33 | ||
| Volatility % | 49.59 | ||
| 14-Day RSI | 58.53 | ||
| 14-Day ATR (Â¥) | 4.736203 | ||
| 20-Day SMA (Â¥) | 110.6785 | ||
| 12-1 Month Momentum % | -15.59 | ||
| 52-Week Range (Â¥) | 78.62 - 135.58 | ||
| Shares Outstanding (Mil) | 123.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Microport Endovascular Medtech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Microport Endovascular Medtech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Microport Endovascular Medtech Co Ltd Frequently Asked Questions
What is Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016)'s stock price today?
The current price of SHSE:688016 is ¥119.10. The 52 week high of SHSE:688016 is ¥135.58 and 52 week low is ¥78.62.
When is next earnings date of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016)?
The next earnings date of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is .
Does Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is 4.01% (As of Today), Highest Dividend Payout Ratio of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) was 0.55. The lowest was 0.22. And the median was 0.3. The  Forward Dividend Yield % of Shanghai Microport Endovascular Medtech Co Ltd(SHSE:688016) is 4.01%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers